Home Newsfeeds JonesTrading Downgrades Concert Pharma to Hold

JonesTrading Downgrades Concert Pharma to Hold

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

byBenzinga Newsdesk

January 20, 2023

1 minute read

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

Jim Cramer Explains What Could Trigger Further Market Decline: ‘If You Want To Get Out, Go Ahead …’

By Benzinga Neuro

April 17, 10:01 PM

CNBC host Jim Cramer has outlined potential factors that could lead to further market decline, advising investors to be cautious about their buying and selling decisions.

AAPL

Why Motion & Control Technologies Provider Parker-Hannifin Shares Are Higher Today

By Lekha Gupta

February 1, 2:35 PM

Parker-Hannifin shares surge after Q2 FY24 results, outperforming with a 3.1% Y/Y sales growth to $4.821 billion. Aerospace Systems lead with a 15% Y/Y sales rise. The company's financial prowess is evident, boasting increased operating cash flow and a declared quarterly cash dividend of $1.48 per share.

Around $3 Million Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Buying

By Lisa Levin

August 3, 9:41 AM

U.S. crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ARTW

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit

By Benzinga Newsdesk

September 28, 2:16 PM

Preclinical and Clinical Presentations Include Update on FRAME Study Low-Grade Serous Ovarian Cancer Efficacy DataVerastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for

VSTM

JonesTrading Downgrades Concert Pharma to Hold

Related Posts

Jim Cramer Explains What Could Trigger Further Market Decline: ‘If You Want To Get Out, Go Ahead …’

Why Motion & Control Technologies Provider Parker-Hannifin Shares Are Higher Today

Around $3 Million Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Buying

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit